1. Pilot study: pudendal neuromodulation combined with pudendal nerve release in case of chronic perineal pain syndrome. The ENTRAMI technique: early results
- Author
-
Luc Bruyninx, Katleen Jottard, Pierre Bonnet, Stefan De Wachter, and Nathalie Mathieu
- Subjects
Male ,Urology ,Pudendal nerve ,030232 urology & nephrology ,Pilot Projects ,03 medical and health sciences ,0302 clinical medicine ,Peripheral nerve ,Humans ,Medicine ,Prospective Studies ,Pudendal Neuralgia ,Perineal pain ,030219 obstetrics & reproductive medicine ,business.industry ,Optimal treatment ,Obstetrics and Gynecology ,Treatment options ,Neuromodulation (medicine) ,Pudendal Nerve ,Clinical trial ,Early results ,Anesthesia ,Female ,Human medicine ,Chronic Pain ,business - Abstract
Introduction and hypothesis Chronic perineal pain syndrome due to pudendal nerve impingement is difficult to diagnose and to treat. All the known treatment options leave room for improvement considering the outcome. Early neuromodulation of the pudendal nerve after its surgical release could improve outcomes. Objectives The aim of the study was to evaluate the potential beneficial effect of pudendal neuromodulation combined with release surgery using the ENTRAMI technique (endoscopic transgluteal minimally invasive technique). Study design This is a single-center prospective descriptive study. Between March 2019 and March 2020, 16 patients (2 males, 14 females) were included. Data were collected at baseline and 1 month after surgery. Methods Patients eligible for inclusion had chronic perineal pain for at least 3 months in the area served by the pudendal nerve. We combined pudendal nerve release with neuromodulation. Results At 1 month, the numeric pain rating scale (NPRS) dropped from 9.5 at baseline to 3.5 (p = 0.003). Seventy-six percent of patients showed a global impression of change (PGIC) of > 50% at 1 month, and optimal treatment response (PGIC >= 90%) was found in 41% of patients. Limitations The drawback of our study was that it was not randomized or blinded. The peripheral nerve evaluation lead (PNE) used could only be implanted for 1 month because of infection risk and is also prone to dislocations and technical failures. Conclusion Pudendal nerve liberation by the ENTRAMI technique combined with short-term pudendal neuromodulation seems feasible and promising in treating patients with chronic perineal pain. Clinical trial number: NCT03880786.
- Published
- 2020
- Full Text
- View/download PDF